Literature DB >> 15158898

Solid-state characterization of rifampicin samples and its biopharmaceutic relevance.

Shrutidevi Agrawal1, Yasvanth Ashokraj, Prasad V Bharatam, Omathanu Pillai, Ramesh Panchagnula.   

Abstract

Polymorphism of rifampicin has been postulated to be responsible for its variable bioavailability from solid oral dosage forms. In this regard, it was believed that form II is the preferred form and the content of amorphous needs to be critically monitored. However, there was no study in literature that determines solubility advantage associated with rifampicin polymorphs and further the desired raw material characteristics for the consistent bioavailability. Hence, this investigation was undertaken with an objective to determine biopharmaceutic relevance of rifampicin physical forms and to propose critical raw material specifications for rifampicin bulk material. For this purpose, solid-state properties of standard form I, form II, amorphous and commercial samples acquired from rifampicin manufacturers were characterized by differential scanning calorimetry (DSC), Fourier transformed infrared spectroscopy (FTIR), hot stage microscopy (HSM), thermogravimetric analysis (TGA), powder X-ray diffraction (p-XRD), solid-state nuclear magnetic resonance (NMR) and molecular modelling. In addition, intrinsic dissolution of standard samples, powder dissolution as well as particle size distribution of all the samples and powder dissolution of various sieve fraction of commercial samples were done in order to study the influence of polymorphism and other factors on rate and extent of dissolution. It was found that rifampicin in commercial bulk samples exist as various combinations of form I, form II and amorphous. As physical forms show comparable intrinsic dissolution rate (IDR) at all the pH values, solubility advantage associated with rifampicin polymorphs is negligible. Nevertheless, powder dissolution of commercial samples was influenced by particle size. In powder dissolution of different sieve fractions of commercial samples, fine particles below 100 microm have shown high rate and extent of dissolution irrespective of polymorphic content, whereas particles above 100 microm exhibited reduced dissolution. In intrinsic dissolution, thermodynamically unstable form II exhibited lower IDR than stable form I. Further, this difference is evident only at pH 2.0 and at all other pH values there was no difference in IDR of these two forms. For this unexpected finding, two hypotheses based on differences in H-bonding of the polymorph have been proposed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15158898     DOI: 10.1016/j.ejps.2004.02.011

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  15 in total

1.  Solid state characterization of commercial crystalline and amorphous atorvastatin calcium samples.

Authors:  Ganesh Shete; Vibha Puri; Lokesh Kumar; Arvind K Bansal
Journal:  AAPS PharmSciTech       Date:  2010-03-30       Impact factor: 3.246

2.  Cryoprotection-lyophilization and physical stabilization of rifampicin-loaded flower-like polymeric micelles.

Authors:  Marcela A Moretton; Diego A Chiappetta; Alejandro Sosnik
Journal:  J R Soc Interface       Date:  2011-08-24       Impact factor: 4.118

3.  Rehydrated lyophilized rifampicin-loaded mPEG-DSPE formulations for nebulization.

Authors:  Juma Masoud Abdulla Abdulla; Yvonne Tze-Fung Tan; Yusrida Darwis
Journal:  AAPS PharmSciTech       Date:  2010-04-20       Impact factor: 3.246

4.  Assessment of juvenile pigs to serve as human pediatric surrogates for preclinical formulation pharmacokinetic testing.

Authors:  Wyatt J Roth; Candice B Kissinger; Robyn R McCain; Bruce R Cooper; Jeremy N Marchant-Forde; Rachel C Vreeman; Sophia Hannou; Gregory T Knipp
Journal:  AAPS J       Date:  2013-04-18       Impact factor: 4.009

5.  Self-Assembled Nanospheres for Encapsulation and Aerosolization of Rifampicin.

Authors:  Aline A Ishikawa; Jesus V Salazar; Magaly Salinas; Cristiane M Gaitani; Timothy Nurkiewicz; George R Negrete; Carlos D Garcia
Journal:  RSC Adv       Date:  2016-01-26       Impact factor: 3.361

6.  Synthesis and characterization of antibacterial drug loaded β-tricalcium phosphate powders for bone engineering applications.

Authors:  Aysenur Topsakal; Nazmi Ekren; Osman Kilic; Faik N Oktar; Mahir Mahirogullari; Ozan Ozkan; Hilal Turkoglu Sasmazel; Mustafa Turk; Iuliana M Bogdan; George E Stan; Oguzhan Gunduz
Journal:  J Mater Sci Mater Med       Date:  2020-01-21       Impact factor: 3.896

7.  Bioavailability of two licensed paediatric rifampicin suspensions: implications for quality control programmes.

Authors:  H McIlleron; H Hundt; W Smythe; A Bekker; J Winckler; L van der Laan; P Smith; H J Zar; A C Hesseling; G Maartens; L Wiesner; A van Rie
Journal:  Int J Tuberc Lung Dis       Date:  2016-07       Impact factor: 2.373

8.  Rifampicin-Carbohydrate Spray-Dried Nanocomposite: A Futuristic Multiparticulate Platform For Pulmonary Delivery.

Authors:  Mohammed M Mehanna; Salma M Mohyeldin; Nazik A Elgindy
Journal:  Int J Nanomedicine       Date:  2019-11-22

9.  Formulation and in vitro evaluation of rifampicin loaded porous microspheres.

Authors:  Satish Balakrishna Bhise; Avinash Bhanudas More; Rajkumar Malayandi
Journal:  Sci Pharm       Date:  2010-04-18

Review 10.  Tuberculosis chemotherapy: current drug delivery approaches.

Authors:  Lisa Claire du Toit; Viness Pillay; Michael Paul Danckwerts
Journal:  Respir Res       Date:  2006-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.